http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111773219-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd5cf244cffd43ac584c793af4641c22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd5f4bcd3c94f842bf9b78c4db31183
publicationDate 2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111773219-A
titleOfInvention Application of PI3K inhibitor NVP-BYL719 in the preparation of novel coronavirus inhibitor
abstract The invention belongs to the field of pharmaceutical technology, and in particular relates to the application of a PI3K inhibitor NVP-BYL719 in the preparation of a novel coronavirus SARS-CoV-2 inhibitor. The results of in vitro cell tests show that the drug can inhibit the novel coronavirus SARS-CoV-2 2 Proliferate in cells. At the same time, the results of the challenge test in mice showed that the drug can effectively reduce the viral load in the lungs of infected mice, and has a significant therapeutic effect on infected mice. It can be used as a novel coronavirus SARS‑CoV‑2 inhibitor for the treatment of COVID‑19 pneumonia.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113082028-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113082028-A
priorityDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022015823-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID170911
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282306
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID561737
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421447813
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID488084
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460858
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID424971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56649450

Total number of triples: 32.